Drugs / WB007
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04149899 | Nov 2019 → Jan 2021 | ocular hypertension, open-angle glaucoma | Bausch & Lomb Incorporated | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WB007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04149899 ↗ |